478P TA-ness classification discriminates RAS wild-type (wt) metastatic colorectal cancer (mCRC) patients (pts) who may benefit from antiEGFR treatment

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 32; p. S570
Main Authors Santos, C., Lawrence, P., Lopez-Doriga, A., Ragulan, C., Fontana, E., Desai, K., Ps, H., Elez Fernandez, M.E., Aranda Aguilar, E., Losa, F., Paez, D., Layos Romero, L., Sanjuan, X., Cañas, M.A., Azuara, D., Queralt, B., Fernandez-Calotti, P., Salazar, R., Sadanandam, A.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.09.2021
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1016/j.annonc.2021.08.999